Orlistat-Acrihin, capsules 60 mg 42 pcs

Lipase inhibitor. When taken orally, orlistat inhibits gastric and pancreatic lipases. As a result, it impairs the breakdown of dietary fats and reduces their absorption from the gastrointestinal tract. With systemic use, this effect leads to weight loss in obese patients. Orlistat is practically not absorbed from the gastrointestinal tract and therefore has almost no resorptive effect.

Indications

Active ingredient

Composition

Capsule body composition:

Patent blue dye – 0.2786%,

Titanium dioxide – 2%,

Gelatin – up to 100%.

Capsule cap composition:

Patent blue dye – 0.2786%,

titanium dioxide – 2%,

gelatin – up to 100%.

How to take, the dosage

Interaction

Special Instructions

It should be borne in mind that the frequency and severity of side effects increase with an increase in the fat content of the food. Reducing the amount of fat in the diet decreases the likelihood of side effects. It is recommended that the amount of fat consumed per day be fairly evenly distributed at all meals.

With treatment, as body weight decreases, the course of pathological processes often associated with obesity, including arterial hypertension, diabetes, and lipid metabolism disorders, may improve.

Contraindications

Side effects

Similarities